HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Nakaraang pagsara
$0.38
Sakop ng araw
$0.36 - $0.38
Sakop ng taon
$0.12 - $0.41
Market cap
678.76M AUD
Average na Volume
10.33M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 188.96K | -89.82% |
Gastos sa pagpapatakbo | 2.46M | 52.31% |
Net na kita | -2.73M | -18.93% |
Net profit margin | -1.45K | -1,068.51% |
Kita sa bawat share | — | — |
EBITDA | -2.76M | -19.90% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 18.31M | 110.12% |
Kabuuang asset | 47.68M | 129.35% |
Kabuuang sagutin | 2.29M | -42.92% |
Kabuuang equity | 45.39M | — |
Natitirang share | 1.55B | — |
Presyo para makapag-book | 12.50 | — |
Return on assets | -14.49% | — |
Return on capital | -15.22% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.73M | -18.93% |
Cash mula sa mga operasyon | -1.88M | 34.38% |
Cash mula sa pag-invest | -7.39M | -189.02% |
Cash mula sa financing | 13.38M | 113.26% |
Net change in cash | 4.03M | 463.80% |
Malayang cash flow | -8.37M | -129.50% |
Tungkol
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Itinatag
1984
Website
Mga Empleyado
11
